| Type | Investment In | % of NAV | No. of shares | Value (Rs cr) |
| Domestic Equities | Sun Pharmaceutical Industries Ltd. | 11.7678 | 52436 | 9.2141 |
| Domestic Equities | Torrent Pharmaceuticals Ltd. | 7.0768 | 13130 | 5.5411 |
| Domestic Equities | Apollo Hospitals Enterprise Ltd. | 6.8383 | 7217 | 5.3543 |
| Domestic Equities | Aurobindo Pharma Ltd. | 5.2145 | 31301 | 4.0829 |
| Domestic Equities | Divi's Laboratories Ltd. | 4.6772 | 6158 | 3.6622 |
| Domestic Equities | Fortis Healthcare Ltd. | 4.3691 | 43032 | 3.4210 |
| Domestic Equities | Onesource Specialty Pharma Ltd. | 4.1695 | 22159 | 3.2647 |
| Domestic Equities | Neuland Laboratories Ltd. | 3.9707 | 2585 | 3.1090 |
| Domestic Equities | Piramal Pharma Ltd. | 3.9426 | 226088 | 3.0870 |
| Domestic Equities | IPCA Laboratories Ltd. | 3.3954 | 16604 | 2.6586 |
| Domestic Equities | Alkem Laboratories Ltd. | 3.3892 | 5008 | 2.6537 |
| Domestic Equities | Glenmark Pharmaceuticals Ltd. | 3.2654 | 11994 | 2.5568 |
| Domestic Equities | Navin Fluorine International Ltd. | 3.2395 | 4116 | 2.5365 |
| Domestic Equities | Abbott India Ltd. | 3.2039 | 968 | 2.5086 |
| Domestic Equities | Cipla Ltd. | 3.0593 | 19567 | 2.3954 |
| Domestic Equities | Gland Pharma Ltd. | 3.0419 | 14043 | 2.3818 |
| Domestic Equities | Concord Biotech Ltd. | 2.6704 | 20531 | 2.0909 |
| Domestic Equities | Metropolis Healthcare Ltd. | 2.6220 | 47304 | 2.0530 |
| Domestic Equities | Artemis Medicare Services Ltd. | 2.4548 | 93529 | 1.9221 |
| Domestic Equities | Mankind Pharma Ltd. | 2.1972 | 8577 | 1.7204 |
| Domestic Equities | Anthem Biosciences Ltd. | 2.1233 | 25333 | 1.6625 |
| Domestic Equities | Max Healthcare Institute Ltd. | 2.0617 | 16775 | 1.6143 |
| Domestic Equities | Acutaas Chemicals Ltd. | 2.0574 | 6296 | 1.6109 |
| Domestic Equities | Dr Agarwal's Health Care Ltd. | 2.0549 | 39576 | 1.6090 |
| Domestic Equities | Global Health Ltd. | 1.8353 | 14952 | 1.4370 |
| Domestic Equities | Vinati Organics Ltd. | 1.4784 | 8741 | 1.1576 |
| Total | | 96.1765 | | 75.3054 |
| Cash & Cash Equivalents and Net Assets | Treps | 3.9749 | | 3.1123 |
| Cash & Cash Equivalents and Net Assets | Net Receivables / (Payables) | -0.1513 | | -0.1185 |
| Total | | 3.8235 | | 2.9938 |
